DOCS
Doximity, Inc. · Healthcare · Medical - Healthcare Information Services
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | -8 | 101.96M | $2.11B | +7 | −14 |
| Q1 2026 | 124 | -12 | 93.12M | $2.18B | +2 | −15 |
| Q4 2025 | 137 | +3 | 98.50M | $4.36B | +5 | −1 |
| Q3 2025 | 20 | -1 | 62.52M | $4.57B | — | −2 |
| Q2 2025 | 19 | 0 | 60.43M | $3.71B | +1 | −1 |
| Q1 2025 | 16 | -1 | 22.41M | $1.30B | +1 | −2 |
| Q4 2024 | 17 | +2 | 19.67M | $1.05B | +2 | — |
| Q3 2024 | 14 | +1 | 14.27M | $621.81M | +2 | −1 |
| Q2 2024 | 13 | — | 13.99M | $391.40M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.38M | — | $66.71M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 2.38M | — | $66.71M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Capital World Investors ✦ | 1.71M | — | $47.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 1.60M | — | $44.84M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 1.14M | — | $31.81M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 503.74K | — | $14.09M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 503.74K | — | $14.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 221.35K | — | $6.19M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 164.18K | — | $4.59M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 162.30K | — | $4.54M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 162.30K | — | $4.54M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 86.30K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 45.85K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 45.85K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 41.72K | — | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 31.34K | — | $870,340 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 31.34K | — | $870,340 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 418 holders, 119.59M shares, $2.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.77K sh · $44,144
Director · 7.50K sh · $293,325
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology